---
figid: PMC6799833__41392_2019_63_Fig7_HTML
figlink: /pmc/articles/PMC6799833/figure/Fig7/
number: Fig. 7
caption: 'The potential mechanisms of fluoxetine in the remission of AD. As a selective
  5-HT reuptake inhibitor, fluoxetine can increase the extraneuronal concentration
  of 5-HT. 5-HT binds to the 5-HT4A receptor to promote neuronal dematuration through
  a Gs-mediated pathway. 5-HT binds to the 5-HT1A receptor, which is involved in BDNF-dependent
  neurogenesis through the Gi-mediated signaling pathway. After 5-HT stimulation,
  MeCP2 is phosphorylated at Ser421 through CaMKII-dependent signaling, and this promotes
  the dissociation of CREB from HDAC and then increases the expression of BDNF. BDNF
  activates downstream signaling pathways, including the MEK-ERK pathway, which might
  promote the activity of α-secretase, inhibit γ-secretase, and reduce the production
  of toxic amyloid Aβ. Moreover, the serotonylation of histone H3 at glutamine 5 (Q5)
  enhances the binding of H3K4me3 and TFIID and allows gene expression. Fluoxetine
  has been reported to bind and inhibit NMDA receptors directly, which can reduce
  the inhibition of α-secretase and thus prevent the production of Aβ. In addition,
  fluoxetine can bind to the endoplasmic reticulum protein sigma-1 receptor, which
  induces the dissociation of Bip from the sigma-1 receptor and promotes neuroprotection.
  5-HT: serotonin; ER: endoplasmic reticulum'
pmcid: PMC6799833
papertitle: History and progress of hypotheses and clinical trials for Alzheimer’s
  disease.
reftext: Pei-Pei Liu, et al. Signal Transduct Target Ther. 2019;4:29.
pmc_ranked_result_index: '21961'
pathway_score: 0.9756061
filename: 41392_2019_63_Fig7_HTML.jpg
figtitle: Potential mechanisms of fluoxetine in the remission of AD
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6799833__41392_2019_63_Fig7_HTML.html
  '@type': Dataset
  description: 'The potential mechanisms of fluoxetine in the remission of AD. As
    a selective 5-HT reuptake inhibitor, fluoxetine can increase the extraneuronal
    concentration of 5-HT. 5-HT binds to the 5-HT4A receptor to promote neuronal dematuration
    through a Gs-mediated pathway. 5-HT binds to the 5-HT1A receptor, which is involved
    in BDNF-dependent neurogenesis through the Gi-mediated signaling pathway. After
    5-HT stimulation, MeCP2 is phosphorylated at Ser421 through CaMKII-dependent signaling,
    and this promotes the dissociation of CREB from HDAC and then increases the expression
    of BDNF. BDNF activates downstream signaling pathways, including the MEK-ERK pathway,
    which might promote the activity of α-secretase, inhibit γ-secretase, and reduce
    the production of toxic amyloid Aβ. Moreover, the serotonylation of histone H3
    at glutamine 5 (Q5) enhances the binding of H3K4me3 and TFIID and allows gene
    expression. Fluoxetine has been reported to bind and inhibit NMDA receptors directly,
    which can reduce the inhibition of α-secretase and thus prevent the production
    of Aβ. In addition, fluoxetine can bind to the endoplasmic reticulum protein sigma-1
    receptor, which induces the dissociation of Bip from the sigma-1 receptor and
    promotes neuroprotection. 5-HT: serotonin; ER: endoplasmic reticulum'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - PIK3CG
  - PIK3R3
  - ARAF
  - PIK3CD
  - BRAF
  - HRAS
  - KRAS
  - RAF1
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - MECP2
  - MAP2K1
  - MAP2K2
  - GRIN3A
  - GRIN3B
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - PIK3R6
  - AKT3
  - AKT1
  - AKT2
  - APP
  - ASS1
  - BDNF
  - HSPA5
  - OPN1LW
  - CREB3
  - CREB1
  - ATF2
  - CREM
  - NRAS
  - SIN3A
  - TBP
  - CREB3L3
  - CREB3L1
  - CREB5
  - MAPK1
  - MAPK3
  - GNAT2
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAO1
  - GNAT1
  - GNAZ
  - GNAT3
  - GNAL
  - GNAS
  - HDAC1
  - CREB3L4
  - ATF1
  - CREB3L2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MeCP2
  symbol: MECP2
  source: hgnc_symbol
  hgnc_symbol: MECP2
  entrez: '4204'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3A
  entrez: '116443'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3B
  entrez: '116444'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN1
  entrez: '2902'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2A
  entrez: '2903'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2C
  entrez: '2905'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2D
  entrez: '2906'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: APP
  symbol: APP
  source: hgnc_symbol
  hgnc_symbol: APP
  entrez: '351'
- word: Aß
  symbol: ASS
  source: hgnc_prev_symbol
  hgnc_symbol: ASS1
  entrez: '445'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: BiP
  symbol: BiP
  source: hgnc_alias_symbol
  hgnc_symbol: HSPA5
  entrez: '3309'
- word: CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Sin3a
  symbol: SIN3A
  source: hgnc_symbol
  hgnc_symbol: SIN3A
  entrez: '25942'
- word: TFIID
  symbol: TFIID
  source: hgnc_alias_symbol
  hgnc_symbol: TBP
  entrez: '6908'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT2
  entrez: '2780'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI1
  entrez: '2770'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI3
  entrez: '2773'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAO1
  entrez: '2775'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT1
  entrez: '2779'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAZ
  entrez: '2781'
- word: Gi
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
- word: Gs
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: Gs
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: HDAC1
  symbol: HDAC1
  source: hgnc_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
